ANALYSIS OF PAIRED BRAFV600E MUTANT GLIOMA PATIENT SAMPLES IDENTIFIES NOVEL RESISTANCE MECHANISMS TO TARGETED BRAF INHIBITION

被引:0
|
作者
Levy, Jean Mulcahy [1 ,2 ]
Sanford, Bridget [1 ]
Morin, Andrew [1 ,2 ]
Green, Adam [1 ,2 ]
Flannery, Patrick [1 ,2 ]
Jones, Kenneth [1 ]
Banerjee, Anurhada [3 ]
Nazemi, Kellie [4 ]
Samuel, David [5 ]
Kilburn, Lindsay [6 ]
Solomon, David [3 ]
Nicolaides, Theodore [3 ]
机构
[1] Univ Colorado Denver, Aurora, CO USA
[2] Morgan Adams Pediat Brain Tumor Res Program, Aurora, CO USA
[3] Univ San Francisco, San Francisco, CA 94117 USA
[4] Oregon Hlth & Sci Univ, Portland, OR USA
[5] Valley Childrens Healthcare, Madera, CA USA
[6] Childrens Natl Hlth Syst, Washington, DC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TBIO-21
引用
收藏
页码:184 / 184
页数:1
相关论文
共 50 条
  • [21] Response and resistance to BRAFV600E inhibition in gliomas: Roadblocks ahead?
    Capogiri, Monica
    De Micheli, Andrea J.
    Lassaletta, Alvaro
    Munoz, Denise P.
    Coppe, Jean-Philippe
    Mueller, Sabine
    Stucklin, Ana S. Guerreiro S.
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [22] Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model
    Grossauer, Stefan
    Koeck, Katharina
    Murphy, Nicole E.
    Meyers, Ian D.
    Daynac, Mathieu
    Truffaux, Nathalene
    Truong, Albert Y.
    Nicolaides, Theodore P.
    McMahon, Martin
    Berger, Mitchel S.
    Phillips, Joanna J.
    James, C. David
    Petritsch, Claudia K.
    ONCOTARGET, 2016, 7 (46) : 75839 - 75853
  • [23] EGFR blockade prevents glioma escape from BRAFV600E targeted therapy
    Yao, Tsun-Wen
    Zhang, Jie
    Prados, Michael
    Weiss, William A.
    James, C. David
    Nicolaides, Theodore
    ONCOTARGET, 2015, 6 (26) : 21993 - 22005
  • [24] Molecular Pathways: Response and Resistance to BRAF and MEK Inhibitors in BRAFV600E Tumors
    Das Thakur, Meghna
    Stuart, Darrin D.
    CLINICAL CANCER RESEARCH, 2014, 20 (05) : 1074 - 1080
  • [26] Senescence Induction by BRAFV600E is Associated With the Induction of Autophagy and Targeted Degradation of BRAF and CRAF
    Hernandez, M. Aguilar
    Patel, B.
    Bate, N.
    Bottrill, A.
    Jin, H.
    Pritchard, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S97 - S97
  • [27] MEK Inhibition Induces Differential Mechanisms of Resistance in Thyroid and Melanoma BRAFV600E Cell Lines
    Dorris, E. R.
    Alhashemi, M.
    Dunne, R.
    Smyth, P.
    O'Leary, J. J.
    Sheils, O.
    MODERN PATHOLOGY, 2013, 26 : 434A - 434A
  • [28] MEK Inhibition Induces Differential Mechanisms of Resistance in Thyroid and Melanoma BRAFV600E Cell Lines
    Dorris, E. R.
    Alhashemi, M.
    Dunne, R.
    Smyth, P.
    O'Leary, J. J.
    Sheils, O.
    LABORATORY INVESTIGATION, 2013, 93 : 434A - 434A
  • [29] Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human Glioma
    Schreck, Karisa C.
    Morin, Andrew
    Zhao, Guisheng
    Allen, Amy N.
    Flannery, Patrick
    Glantz, Michael
    Green, Adam L.
    Jones, Chris
    Jones, Kenneth L.
    Kilburn, Lindsay B.
    Nazemi, Kellie J.
    Samuel, David
    Sanford, Bridget
    Solomon, David A.
    Wang, Jiawan
    Pratilas, Christine A.
    Nicolaides, Theodore
    Levy, Jean M. Mulcahy
    CLINICAL CANCER RESEARCH, 2021, 27 (22) : 6197 - 6208
  • [30] RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition
    Ponzone, Luca
    Audrito, Valentina
    Landi, Claudia
    Moiso, Enrico
    Levron, Chiara Levra
    Ferrua, Sara
    Savino, Aurora
    Vitale, Nicoletta
    Gasparrini, Massimiliano
    Avalle, Lidia
    Vantaggiato, Lorenza
    Shaba, Enxhi
    Tassone, Beatrice
    Saoncella, Stefania
    Orso, Francesca
    Viavattene, Daniele
    Marina, Eleonora
    Fiorilla, Irene
    Burrone, Giulia
    Abili, Youssef
    Altruda, Fiorella
    Bini, Luca
    Deaglio, Silvia
    Defilippi, Paola
    Menga, Alessio
    Poli, Valeria
    Porporato, Paolo Ettore
    Provero, Paolo
    Raffaelli, Nadia
    Riganti, Chiara
    Taverna, Daniela
    Cavallo, Federica
    Calautti, Enzo
    MOLECULAR CANCER, 2024, 23 (01)